Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1-34) treatment in a rabbit tibial lengthening model.

UNLABELLED Since the approval of parathyroid hormone (PTH) as treatment for osteoporosis, PTH has increasingly been investigated for bone repair and regeneration. The aim of the study was to investigate the effects of intermittent PTH treatment on the microstructure of regenerated mineralizing tissue after distraction osteogenesis in rabbits. After tibial mid-diaphyseal osteotomy the callus was distracted 1 mm/day for 10 days. 72 rabbits were divided in to 3 groups, which daily received a PTH (1-34) 25 microg/kg injection for 30 days; a saline injection for 10 days and a PTH injection for 20 days; or a saline injection for 30 days. The microstructure of the regenerate was assessed by micro computed tomography (microCT). In all 51 obtained specimens were evaluated morphometrically using three different volumes of interests. The results showed that treatment with PTH during distraction osteogenesis resulted in a significantly higher trabecular number, a more isotropic trabecular orientation, a higher connectivity density, and a higher mineralizing tissue mass. We also found that distraction calluses treated with PTH were more mature than the non-treated. CONCLUSION treatment with PTH resulted in an enhanced microstructure of the newly regenerated mineralizing tissue indicating that PTH has a potential role as a stimulating agent during distraction osteogenesis.

[1]  I. Hvid,et al.  Parathyroid hormone PTH(1–34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits , 2009, Acta orthopaedica.

[2]  S. Kakar,et al.  Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. , 2008, The Journal of bone and joint surgery. American volume.

[3]  R. Recker,et al.  Increases in BMD Correlate With Improvements in Bone Microarchitecture With Teriparatide Treatment in Postmenopausal Women With Osteoporosis , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  D. Burr,et al.  Interrelationships Between Bone Microarchitecture and Strength in Ovariectomized Monkeys Treated With Teriparatide , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  N. Lane,et al.  Parathyroid hormone update. , 2006, Rheumatic diseases clinics of North America.

[6]  T. Thomas Intermittent parathyroid hormone therapy to increase bone formation. , 2006, Joint, bone, spine : revue du rhumatisme.

[7]  T. Einhorn,et al.  Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. , 2005, Bone.

[8]  S Prohaska,et al.  Stereological measures of trabecular bone structure: comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies , 2005, Journal of microscopy.

[9]  B. Mitlak,et al.  Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). , 2005, The Journal of bone and joint surgery. American volume.

[10]  S. Komatsubara,et al.  Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. , 2005, Bone.

[11]  P. Aspenberg,et al.  Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  J. F. Whitfield,et al.  Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase , 2004, Calcified Tissue International.

[13]  H. Genant,et al.  Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  R. Skripitz,et al.  Histomorphometry of Distraction Osteogenesis During Experimental Tibial Lengthening , 2003, Journal of orthopaedic trauma.

[15]  W. Landis,et al.  Organization of apatite crystals in human woven bone. , 2003, Bone.

[16]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[17]  C. Fledelius,et al.  Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone , 2001, Acta orthopaedica Scandinavica.

[18]  I. Hvid,et al.  Quantification of age-related changes in the structure model type and trabecular thickness of human tibial cancellous bone. , 2000, Bone.

[19]  P. Aspenberg,et al.  Strong effect of PTH (1-34) on regenerating bone: A time sequence study in rats , 2000, Acta orthopaedica Scandinavica.

[20]  S A Goldstein,et al.  Temporal and Spatial Characterization of Regenerate Bone in the Lengthened Rabbit Tibia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  L. Mosekilde,et al.  Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). , 1999, Bone.

[22]  P. Rüegsegger,et al.  Direct Three‐Dimensional Morphometric Analysis of Human Cancellous Bone: Microstructural Data from Spine, Femur, Iliac Crest, and Calcaneus , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  H. Oxlund,et al.  Intermittent Parathyroid Hormone (1–34) Treatment Increases Callus Formation and Mechanical Strength of Healing Rat Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  Toru Hirano,et al.  Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in Rabbits , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  T. Wronski,et al.  Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. , 1999, Bone.

[26]  P. Rüegsegger,et al.  Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. , 1998, Bone.

[27]  H. Takahashi,et al.  Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. , 1997, Bone.

[28]  J Aronson,et al.  Limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method. , 1997, The Journal of bone and joint surgery. American volume.

[29]  R. Boyce,et al.  Effects of intermittent hPTH(1–34) alone and in combination with 1,25(OH)2d3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  D. Thompson,et al.  FDA Guidelines and animal models for osteoporosis. , 1995, Bone.

[31]  L. Mosekilde Assessing bone quality--animal models in preclinical osteoporosis research. , 1995, Bone.

[32]  I. Hvid,et al.  Distraction effects on muscle. Leg lengthening studied in rabbits. , 1994, Acta orthopaedica Scandinavica.

[33]  H. Gundersen,et al.  Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. , 1993, Bone.

[34]  S. Goldstein,et al.  Evaluation of a microcomputed tomography system to study trabecular bone structure , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[35]  G A Ilizarov,et al.  The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. , 1989, Clinical orthopaedics and related research.

[36]  S. Goldstein,et al.  The direct examination of three‐dimensional bone architecture in vitro by computed tomography , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  R. Recker,et al.  Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. , 2009, Bone.

[38]  真鍋 健史 Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys , 2008 .

[39]  P. Rüegsegger,et al.  A microtomographic system for the nondestructive evaluation of bone architecture , 2006, Calcified Tissue International.

[40]  I. Hvid,et al.  Effects of parathyroid hormone on newly regenerated bone during distraction osteogenesis in a rabbit tibial lengthening model. A pilot study. , 2006, Medicina.

[41]  R. Lindsay,et al.  The Anabolic Effects of Parathyroid Hormone , 2002, Osteoporosis International.

[42]  J. Reeve,et al.  Treatment with PTH Peptides , 2001 .

[43]  Gavriil A. Ilizarov,et al.  The Tension-Stress Effect on the Genesis and Growth of Tissues , 1992 .

[44]  W. Jee,et al.  Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. , 1990, Bone.

[45]  C. Delloye,et al.  Bone regenerate formation in cortical bone during distraction lengthening. An experimental study. , 1990, Clinical orthopaedics and related research.

[46]  G A Ilizarov,et al.  Clinical application of the tension-stress effect for limb lengthening. , 1990, Clinical orthopaedics and related research.

[47]  G A Ilizarov,et al.  The tension-stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. , 1989, Clinical orthopaedics and related research.